Malaria P.f/Pan Antigen Rapid Test
Malaria P.f/Pan Antigen Rapid Test
Product Introduction
The Malaria P.f/Pan Antigen Rapid Test is a highly reliable, dual-antigen rapid diagnostic test designed for the rapid detection and differentiation of malaria parasites. This advanced immunoassay simultaneously detects Histidine-Rich Protein 2 (HRP2) specific to Plasmodium falciparum (P.f) and Plasmodium Lactate Dehydrogenase (pLDH) common to all malaria species (Pan), allowing clear distinction between P. falciparum and non-falciparum malaria (P.v, P.o, P.m) from a single blood sample.
By providing accurate results in just 15–20 minutes, the test enables healthcare professionals to quickly identify high-risk P. falciparum infections — the most dangerous form of malaria — and efficiently screen for other malaria strains. This dual-biomarker approach significantly improves diagnostic accuracy and supports timely clinical decision-making in both endemic and non-endemic regions.
Key Features and Benefits
- Dual-Antigen Detection: Simultaneously detects HRP2 (P.f-specific) and pLDH (Pan malaria), enabling differentiation between P. falciparum and non-falciparum species in one test.
- Rapid & Reliable Results: Delivers clear, easy-to-read results within 15–20 minutes, facilitating fast patient triage and treatment initiation.
- High Sensitivity for P.f: Excellent performance in detecting P. falciparum, the species responsible for the majority of severe malaria cases and deaths.
- Convenient Sample Type: Requires only a small volume of whole blood (fingerstick or venous), making it ideal for resource-limited settings and point-of-care (POC) testing.
- Professional Use: Designed for use by trained healthcare professionals in hospitals, clinics, mobile clinics, and field screening programs.
- Essential Screening Tool: Serves as an effective primary screening test to guide further confirmation by microscopy or molecular methods when needed.
Intended Use
The Malaria P.f/Pan Antigen Rapid Test is a lateral flow chromatographic immunoassay intended for the qualitative detection of Plasmodium falciparum specific HRP2 and Pan malaria pLDH antigens in human whole blood specimens. It is intended to be used as an aid in the diagnosis of malaria infection and for the differentiation of P. falciparum from other malaria species.
For In Vitro Diagnostic use only.
This Malaria P.f/Pan Antigen Rapid Test offers a streamlined, efficient, and cost-effective solution for malaria screening. In high-burden areas, it plays a critical role in early diagnosis, prompt treatment, and effective malaria control strategies, ultimately helping to save lives and reduce the burden of this life-threatening disease.
FAQs:
1. What is a Malaria P.f/Pan Antigen Rapid Test?
It is a rapid diagnostic tool used for the qualitative detection and differential diagnosis of malaria infections in human blood specimens.
2. How does the P.f/Pan test differentiate between malaria species?
The test detects HRP2 (Histidine-rich protein II) specific to Plasmodium falciparum and pLDH (Plasmodium lactate dehydrogenase) common to all Plasmodium species.
3. What does a positive "P.f" result indicate?
A positive P.f result specifically indicates an infection caused by Plasmodium falciparum, which is often associated with more severe forms of malaria.
4. What does the "Pan" marker detect in this malaria test?
The Pan marker identifies the presence of various malaria species, including P. vivax, P. malariae, and P. ovale, by targeting the pLDH enzyme.
5. Is this malaria antigen test intended for professional use?
Yes, it is designed for use by healthcare professionals as an initial screening tool in clinics, hospitals, and point-of-care settings.
6. What specimen type is required for the Malaria P.f/Pan test?
The test is performed using human blood specimens, which can typically be obtained via a finger prick or venous collection.
7. How long does it take to get results from the malaria rapid test?
This rapid diagnostic kit provides easy-to-read qualitative results within 15 to 20 minutes, allowing for immediate patient assessment.
8. Should reactive specimens be confirmed by other methods?
Yes, all reactive specimens should be confirmed by supplemental assays, such as a microscopic examination of a thin blood smear.
9. What are the clinical benefits of the P.f/Pan combo test?
It allows for rapid triage by distinguishing between the most dangerous species (P. falciparum) and other malaria parasites in a single device.
10. Is any specialized laboratory equipment needed?
No, this is a self-contained rapid test cassette that does not require additional instrumentation for processing or interpretation.
11. What is HRP2 in the context of malaria testing?
HRP2 is a water-soluble protein released by Plasmodium falciparum that serves as a highly specific biomarker for this particular parasite.
12. What is the role of pLDH in the Pan test line?
pLDH is an enzyme produced by all four major human malaria parasites, making it an ideal marker for a broad-spectrum "Pan" detection line.
13. Is the Malaria P.f/Pan test suitable for In Vitro Diagnostic (IVD) use?
Yes, this product is strictly intended for professional In Vitro Diagnostic (IVD) use only.
14. How should the malaria rapid test kits be stored?
The kits should be stored in their original packaging at the manufacturer's specified temperatures (typically 2–30°C) to maintain stability.
15. Can this test help in resource-limited environments?
Yes, its simple procedure, fast turnaround, and lack of equipment requirements make it essential for malaria management in remote or field-based areas.













